In summary, for the first time, B2-CIC (IgG and IgM) has been described and its presence has been associated with clinical manifestations related to APS as thrombocytopenia, LR, sicca ophthalmic, and leukopenia as well as higher complement consumption. This evidence concerns the gene CD40LG and Thrombocytopenia.